Evidence map›Paper›PMID 40310467›Full record

ArticleeLife2025

Complex system modeling reveals oxalate homeostasis is driven by diverse oxalate-degrading bacteria.

Sromona D Mukherjee, Carlos Batagello, Ava Adler, Jose Agudelo, Anna Zampini, Mangesh Suryavanshi, Andrew Nguyen, Terry Orr, Denise Dearing, Manoj Monga and 1 more

Abstract read
In one paragraph

Article in eLife, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Gut microbes · 2025
    Article
  4. Microbiota and kidney disease: the road ahead.Nature reviews. Nephrology · 2025
    Review
  5. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Sromona D MukherjeeDepartment of Cardiovascular and Metabolic Sciences, Cleveland Clinic, Cleveland, United States.ORCID https://orcid.org/0000-0003-1958-0220
Carlos BatagelloDivision of Urology, Hospital das Clínicas, University of Sao Paulo Medical School, Sao Paulo, Brazil.
Ava AdlerDepartment of Urology, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, United States.
Jose AgudeloDepartment of Cardiovascular and Metabolic Sciences, Cleveland Clinic, Cleveland, United States.
Anna ZampiniDepartment of Urology, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, United States.
Mangesh SuryavanshiDepartment of Cardiovascular and Metabolic Sciences, Cleveland Clinic, Cleveland, United States.
Andrew NguyenM Health Fairview Southdale Hospital, Edina, United States.
Terry OrrDepartment of Biology, New Mexico State University, Las Cruces, United States.
Denise DearingSchool of Biological Sciences, University of Utah, Salt Lake City, United States.
Manoj MongaDepartment of Urology, University of California San Diego, San Diego, United States.
Aaron W MillerDepartment of Cardiovascular and Metabolic Sciences, Cleveland Clinic, Cleveland, United States.ORCID https://orcid.org/0000-0001-8342-1449

Funding

The role of acetogenic, methanogenic, and sulfate-reducing bacteria in oxalate metabolism and hyperoxaluriaR01DK121689 · NIDDK · CLEVELAND CLINIC LERNER COM-CWRU · PI MILLER, AARON W · 2020 to 2024
$2.3M
NIDDK NIH HHS R01 DK121689NIH HHS DK121689-01A1
6 · The paper itself

Abstract

Decades of research have made clear that host-associated microbiomes touch all facets of health. However, effective therapies that target the microbiome have been elusive given its inherent complexity. Here, we experimentally examined diet-microbe-host interactions through a complex systems framework, centered on dietary oxalate. Using multiple, independent molecular, rodent, and in vitro experimental models, we found that microbiome composition influenced multiple oxalate-microbe-host interfaces. Importantly, the administration of the oxalate-degrading specialist,

Indexed as

BacteriaGastrointestinal MicrobiomeHomeostasisOxalatesOxalobacter formigenesAnimalsHost Microbial InteractionsMiceOxalateshyperoxaluriainfectious diseasemetabolomemicrobiologymicrobiomemouseNeotoma albigulaoxalateprobiotics

Identifiers

PMID40310467
PMCPMC12045624

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.